June 8, 2017 – The U.S. Food and Drug Administration has approved the first generic version of Truvada for the treatment of HIV-1, in combination with other antiretroviral agents, and for pre-exposure prophylaxis (PrEP) in combination with safer sex…Original Article
FDA Approves First Generic Truvada for HIV Infection and Pre-Exposure Prophylaxis (PrEP)
